Integrated Diagnostics Holdings plc (IDHC) Share Price & Analysis

Open: 0.52
High: 0.52
Low: 0.51
Close: 0.51
Change: -0.01 (-2.72%)
Volume: 258,847

1M Performance: -5.7%
3M Performance: -2.0%
1Y Performance: -0.0%
Market Cap: $296m
Avg Daily Volume: 191.1K

52-Week Range

0.48(23 Mar 26)0.83(13 Jan 26)

Current 0.51 · position in 52-week range

Revenue:	EGP 7.9B
Operating Profit:	EGP 2.2B
Profit After Tax:	EGP 1.3B
Total Assets:	EGP 8.6B
Shareholders' Equity:	EGP 4.1B
Current Ratio:	1.46
Operating Cash Flow:	EGP 1.9B

As at Dec 20256 years of data

15 Oct 2026	14:42:59	Director/PDMR Shareholding
11 Sept 2026	07:00:03	Half-year Report
4 Sept 2026	11:23:13	Notice of Results
17 Aug 2026	17:25:06	Director/PDMR Shareholding

17 Apr 2026	Annual Financial Report
24 Apr 2025	Annual Financial Report
4 Apr 2024	Annual Financial Report

Yvonne StillhartNon-Executive Director and Chair of the Audit Committee

–

Hussein ChoucriNon-Executive Director and Chair of the Remuneration Committee

–

Lord St John of BletsoNon-Executive Chair

–

Prof. Dr. Hend El SherbiniGroup Chief Executive Officer

–

Sherif El ZeinyGroup Chief Financial Officer and Executive Director

Integrated Diagnostics Holdings plc (IDH) operates as a consumer-focused diagnostics platform and is one of the largest clinical laboratory operators in the Middle East and Africa. The company provides a comprehensive range of over 3,000 diagnostic tests, including pathology, radiology, and radiotherapy services. IDH generates revenue primarily through its clinical laboratory services, catering to customers in Egypt, Jordan, Nigeria, Sudan, and Saudi Arabia, with a strategic focus on expanding its geographic presence and enhancing service offerings.

Industry: Health Care
Sector: Health Care
LEI: 2138007JN9NUWKKTS790
Issuer: Integrated Diagnostics Holdings plc
Region: Europe
Admission date: 11 May 2015
Website: www.idhcorp.com

Open: 0.52
High: 0.52
Low: 0.51
Close: 0.51
Change: -0.01 (-2.72%)
Volume: 258,847

1M Performance: -5.7%
3M Performance: -2.0%
1Y Performance: -0.0%
Market Cap: $296m
Avg Daily Volume: 191.1K

52-Week Range

0.48(23 Mar 26)0.83(13 Jan 26)

Current 0.51 · position in 52-week range

Revenue:	EGP 7.9B
Operating Profit:	EGP 2.2B
Profit After Tax:	EGP 1.3B
Total Assets:	EGP 8.6B
Shareholders' Equity:	EGP 4.1B
Current Ratio:	1.46
Operating Cash Flow:	EGP 1.9B

As at Dec 20256 years of data

15 Oct 2026	14:42:59	Director/PDMR Shareholding
11 Sept 2026	07:00:03	Half-year Report
4 Sept 2026	11:23:13	Notice of Results
17 Aug 2026	17:25:06	Director/PDMR Shareholding

17 Apr 2026	Annual Financial Report
24 Apr 2025	Annual Financial Report
4 Apr 2024	Annual Financial Report

Yvonne StillhartNon-Executive Director and Chair of the Audit Committee

–

Hussein ChoucriNon-Executive Director and Chair of the Remuneration Committee

–

Lord St John of BletsoNon-Executive Chair

–

Prof. Dr. Hend El SherbiniGroup Chief Executive Officer

–

Sherif El ZeinyGroup Chief Financial Officer and Executive Director

Industry: Health Care
Sector: Health Care
LEI: 2138007JN9NUWKKTS790
Issuer: Integrated Diagnostics Holdings plc
Region: Europe
Admission date: 11 May 2015
Website: www.idhcorp.com

Going concern: No material uncertainty
Audit opinion: Unqualified
Principal risks: 1

Shares in issueas at 19 May 2026: 581,326,272
Total Voting Rights: 581,326,272

Last updated: 16 October 2026

Latest year: FY25
Declared per share: $0.01
Total paid: $535.1M

ISIN: JE00BLKGSR75
Exchange: XLON
Market: Main Market
Market Segment: SET3
Market Sector: ON15
Security Description: Ordinary Shares of USD0.25 each; fully paid
Listing Category: Equity shares (transition)

Going concern: No material uncertainty
Audit opinion: Unqualified
Principal risks: 1

Shares in issueas at 19 May 2026: 581,326,272
Total Voting Rights: 581,326,272

Last updated: 16 October 2026

Latest year: FY25
Declared per share: $0.01
Total paid: $535.1M

ISIN: JE00BLKGSR75
Exchange: XLON
Market: Main Market
Market Segment: SET3
Market Sector: ON15
Security Description: Ordinary Shares of USD0.25 each; fully paid
Listing Category: Equity shares (transition)

Integrated Diagnostics Holdings plc

Integrated Diagnostics Holdings plc

Price Chart

Key Statistics

Financial Summary

Financial Health

Recent RNS announcements

Annual Reports

Directors (8)

Company details

Revenue Trend